VIR logo

VIR
Vir Biotechnology Inc

6,334
Mkt Cap
$930.75M
Volume
1.27M
52W High
$14.45
52W Low
$4.16
PE Ratio
-1.85
VIR Fundamentals
Price
$6.72
Prev Close
$6.69
Open
$6.77
50D MA
$5.93
Beta
1.52
Avg. Volume
1.5M
EPS (Annual)
-$3.83
P/B
1.17
Rev/Employee
$181,875.00
Loading...
Loading...
News
all
press releases
12,916,663 Shares in Vir Biotechnology, Inc. $VIR Bought by ARCH Venture Management LLC
ARCH Venture Management LLC purchased a new position in shares of Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) during the 2nd quarter, according to the company in its most recent filing with...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - Should You Buy?
Vir Biotechnology (NASDAQ:VIR) Shares Gap Up - Still a Buy...
MarketBeat·7d ago
News Placeholder
Insider Selling: Vir Biotechnology (NASDAQ:VIR) Major Shareholder Sells 191,854 Shares of Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 191,854 shares of the business's stock in a transaction that occurred on Monday, December 1st...
MarketBeat·11d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 191,854 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 191,854 shares of the firm's stock in a transaction on Monday, December 1st. The shares were...
MarketBeat·11d ago
News Placeholder
Vir Biotechnology, Inc. (NASDAQ:VIR) Given Consensus Recommendation of "Moderate Buy" by Analysts
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) has been given an average rating of "Moderate Buy" by the eleven analysts that are currently covering the stock, MarketBeat.com reports. One...
MarketBeat·12d ago
News Placeholder
Insider Selling: Vir Biotechnology (NASDAQ:VIR) Director Sells 22,000 Shares of Stock
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) Director Vicki Sato sold 22,000 shares of Vir Biotechnology stock in a transaction that occurred on Monday, December 1st. The shares were sold...
MarketBeat·12d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Shares Down 7.1% - What's Next?
Vir Biotechnology (NASDAQ:VIR) Trading Down 7.1% - Here's Why...
MarketBeat·13d ago
News Placeholder
Ensign Peak Advisors Inc Increases Position in Vir Biotechnology, Inc. $VIR
Ensign Peak Advisors Inc boosted its position in Vir Biotechnology, Inc. (NASDAQ:VIR - Free Report) by 812.7% during the second quarter, according to the company in its most recent Form 13F filing...
MarketBeat·18d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 235,971 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 235,971 shares of the business's stock in a transaction that occurred on Tuesday, November...
MarketBeat·18d ago
News Placeholder
Vir Biotechnology (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 227,803 Shares
Vir Biotechnology, Inc. (NASDAQ:VIR - Get Free Report) major shareholder Endurance (Cayman) Ltd Svf sold 227,803 shares of the stock in a transaction on Monday, November 24th. The shares were sold at...
MarketBeat·18d ago
<
1
2
...
>

Latest VIR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.